MEDICAPS

MediCaps Share Price

 

 

Start SIP in MEDICAPS

Start SIP
MediCaps live price: ₹24.2. It opened at ₹24 vs previous close ₹24; intraday high/low: ₹25/₹24. The 50 & 200 DMA stand at ₹27.30/₹35.17.

MediCaps Performance

  • Low
  • ₹24
  • High
  • ₹25
  • 52 Week Low
  • ₹21
  • 52 Week High
  • ₹50
  • Open Price₹24
  • Previous Close₹24
  • Volume7,503
  • 50 DMA₹27.30
  • 100 DMA₹30.74
  • 200 DMA₹35.17

Investment Returns

  • Over 1 Month -4.95%
  • Over 3 Month -28.08%
  • Over 6 Month -40.39%
  • Over 1 Year -47.49%

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -6.9
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 30
  • P/B Ratio
  • 0.3
  • Average True Range
  • 2.32
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.28
  • RSI
  • 41.85
  • MFI
  • 42.34

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹24.20
+ 0.38 (1.6%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹24.73
  • 50 Day
  • ₹27.30
  • 100 Day
  • ₹30.74
  • 200 Day
  • ₹35.17

Resistance and Support

23.62 Pivot Speed
  • R3 28.15
  • R2 26.57
  • R1 25.20
  • S1 22.25
  • S2 20.67
  • S3 19.30

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-05 Quarterly Results
2025-05-21 Audited Results
2025-02-12 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

No data available.

MediCaps FAQs

MediCaps share price is ₹24 As on 05 March, 2026 | 14:48

The Market Cap of MediCaps is ₹30.2 Cr As on 05 March, 2026 | 14:48

The P/E ratio of MediCaps is -6.9 As on 05 March, 2026 | 14:48

The PB ratio of MediCaps is 0.3 As on 05 March, 2026 | 14:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23